Nasdaq FDA - Search News

FDA, Novo Nordisk and Shortage

US FDA Says Shortage of Novo's Weight-Loss Drug Resolved

All doses of Novo's diabetes treatment Ozempic and weight-loss drug Wegovy were listed as available on the FDA's website in October, but the treatments were not taken off the offi

Wall Street Journal · 23h

Novo Nordisk Shares Rise After FDA Clears Shortage of Anti-Obesity Drugs

Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o

Investor's Business Daily on MSN · 1d

Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage

Hims stock dropped sharply Friday after the U.S. Food and Drug Administration said the shortage of widely-used weight-loss and diabetes drugs has been resolved. The FDA website indicated that the shortage of Novo Nordisk's Ozempic and Wegovy has ended.

4don MSN

Teva and Alvotech gets FDA review acceptance for its proposed biosimilar to Eylea

Alvotech (NASDAQ:ALVO) and Teva Pharmaceuticals (NYSE:TEVA) said on Tuesday that the U.S. FDA has accepted for review a ...

Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq

The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing breakthrough innovations in FDA approved drugs, ...

Nasdaq3d

Harmony Biosciences Receives FDA Refusal To File Letter For Pitolisant In Idiopathic Hypersomnia

(RTTNews) - Harmony Biosciences Holdings, Inc. (HRMY) Wednesday said that it received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for pitolisant for the ...

5hon MSN

Travere Therapeutics, Inc. (NASDAQ:TVTX) Q4 2024 Earnings Call Transcript

Q4 2024 Earnings Call Transcript February 21, 2025 Operator: Good afternoon, and welcome to the Travere Therapeutics Fourth ...

MassDevice1d

iRhythm stock rises on Q4 results, on-target FDA remediation efforts

Rhythm (Nasdaq: IRTC) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast on Wall ...

Nasdaq4d

Spectral AI Strengthens Financial Position Ahead of FDA Submission

DALLAS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI ... Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses multi-spectral imaging and AI ...

1don MSN

Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2024 Earnings Call Transcript

Q4 2024 Earnings Call Transcript February 20, 2025 Dynavax Technologies Corporation reports earnings inline with expectations ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results